BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,132,608 | +79.7% | 69,629 | +162.9% | 0.03% | +100.0% |
| Q3 2022 | $1,743,000 | -14.4% | 26,484 | +33.6% | 0.02% | -28.6% |
| Q3 2021 | $2,037,000 | -33.1% | 19,818 | -27.0% | 0.02% | -48.8% |
| Q4 2020 | $3,044,000 | +411.6% | 27,137 | +323.0% | 0.04% | +272.7% |
| Q3 2020 | $595,000 | +141.9% | 6,415 | +108.7% | 0.01% | +83.3% |
| Q4 2019 | $246,000 | -90.1% | 3,074 | -90.9% | 0.01% | -91.8% |
| Q3 2019 | $2,484,000 | -81.6% | 33,800 | -76.4% | 0.07% | -84.8% |
| Q2 2019 | $13,536,000 | +38.6% | 143,500 | +17.6% | 0.48% | +41.3% |
| Q1 2019 | $9,766,000 | +853.7% | 122,000 | +797.9% | 0.34% | +303.6% |
| Q4 2017 | $1,024,000 | +43.4% | 13,588 | -23.9% | 0.08% | +16.7% |
| Q1 2017 | $714,000 | – | 17,849 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |